Skip to main content
SpringerLink
Log in

Genital Candidiasis

  • Chapter
  • First Online:
Sexually Transmitted Infections and Sexually Transmitted Diseases

Abstract

Candidiasis continues to be an extremely common cause of vulvovaginal symptoms and is still most commonly due to Candida albicans.

Major progress has been made in recognizing the role of host genetic factors in pathogenesis of sporadic and recurrent vulvovaginal candidiasis (VVC).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hurley, R., De Louvois, J.: Candida vaginitis. Postgrad. Med. J. 55, 645–647 (1979)

    Article  PubMed  CAS  Google Scholar 

  2. Foxman, B., Marsh, J.V., Gillespie, B., Sobel, J.D.: Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey. J. Womens Health 7, 1167–1174 (1998)

    Article  PubMed  CAS  Google Scholar 

  3. Berg, A.O., Heidrich, F.E., Fihn, S.D., et al.: Establishing the cause of genitourinary symptoms in women in a family practice. Comparison of clinical examination and comprehensive microbiology. JAMA 251, 620–625 (1984)

    Article  PubMed  CAS  Google Scholar 

  4. Eckert, L.O., Hawes, S.E., Stevens, C.E., Koutsky, L.A., Eschenbach, D.A., Holmes, K.K.: Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet. Gynecol. 92, 757–765 (1998)

    Article  PubMed  CAS  Google Scholar 

  5. Foxman, B., Barlow, R., D’Arcy, H., Gillespie, B., Sobel, J.D.: Candida vaginitis: self-reported incidence and associated costs. Sex. Transm. Dis. 27, 230–235 (2000)

    Article  PubMed  CAS  Google Scholar 

  6. Anderson, M.R., Klink, K., Cohrssen, A.: Evaluation of vaginal complaints. JAMA 291, 1368–1379 (2004)

    Article  PubMed  CAS  Google Scholar 

  7. Goldacre, M.J., Watt, B., Loudon, N., Milne, L.J., Loudon, J.D., Vessey, M.P.: Vaginal microbial flora in normal young women. Br. Med. J. 1, 1450–1455 (1979)

    Article  PubMed  CAS  Google Scholar 

  8. Carpenter, C.C., Mayer, K.H., Fisher, A., Desai, M.B., Durand, L.: Natural history of acquired immunodeficiency syndrome in women in Rhode Island. Am. J. Med. 86, 771–775 (1989)

    Article  PubMed  CAS  Google Scholar 

  9. Sobel, J.D.: Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am. J. Obstet. Gynecol. 152, 924–935 (1985)

    PubMed  CAS  Google Scholar 

  10. Sobel, J.D.: Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. N. Engl. J. Med. 315, 1455–1458 (1986)

    Article  PubMed  CAS  Google Scholar 

  11. Erdem, H., Cetin, M., Timuroglu, T., Cetin, A., Yanar, O., Pahsa, A.: Identification of yeasts in public hospital primary care patients with or without clinical vaginitis. Aust. NZ. J. Obstet. Gynaecol. 43, 312–316 (2003)

    Article  Google Scholar 

  12. Holland, J., Young, M.L., Lee, O., C-A Chen, S.: Vulvovaginal carriage of yeasts other than Candida albicans. Sex. Transm. Infect. 79, 249–250 (2003)

    Article  PubMed  CAS  Google Scholar 

  13. Bauters, T.G., Dhont, M.A., Temmerman, M.I., Nelis, H.J.: Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am. J. Obstet. Gynecol. 187, 569–574 (2002)

    Article  PubMed  CAS  Google Scholar 

  14. Corsello, S., Spinillo, A., Osnengo, G., et al.: An epidemiological survey of vulvovaginal candidiasis in Italy. Eur. J. Obstet. Gynecol. Reprod. Biol. 110, 66–72 (2003)

    Article  PubMed  Google Scholar 

  15. Cauwenbergh, G.: Vaginal candidiasis: Evolving trends in the incidence and treatment of non-Candida albicans infection. Curr. Probl. Obstet. Gynecol. Fertil. 8, 241 (1990)

    Google Scholar 

  16. Sobel, J.D., Brooker, D., Stein, G.E., et al.: Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group. Am. J. Obstet. Gynecol. 172, 1263–1268 (1995)

    Article  PubMed  CAS  Google Scholar 

  17. Sobel, J.D., Wiesenfeld, H.C., Martens, M., et al.: Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N. Engl. J. Med. 351, 876–883 (2004)

    Article  PubMed  CAS  Google Scholar 

  18. Nyirjesy, P., Alexander, A.B., Weitz, M.V.: Vaginal Candida parapsilosis: pathogen or bystander? Infect. Dis. Obstet. Gynecol. 13, 37–41 (2005)

    Article  PubMed  Google Scholar 

  19. Singh, S., Sobel, J.D., Bhargava, P., Boikov, D., Vazquez, J.A.: Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy. Clin. Infect. Dis. 35, 1066–1070 (2002)

    Article  PubMed  Google Scholar 

  20. Sobel, J.D., Myers, P.G., Kaye, D., Levison, M.E.: Adherence of Candida albicans to human vaginal and buccal epithelial cells. J. Infect. Dis. 143, 76–82 (1981)

    Article  PubMed  CAS  Google Scholar 

  21. Macura, A.B., Voss, A., Melchers, W.J., Meis, J.F., Syslo, J., Heczko, P.B.: Characterization of pathogenetic determinants of Candida albicans strains. Zentralbl. Bakteriol. 287, 501–508 (1998)

    PubMed  CAS  Google Scholar 

  22. Taylor, B.N., Staib, P., Binder, A., et al.: Profile of Candida albicans – secreted aspartic proteinase elicited during vaginal infection. Infect. Immun. 73, 1828–1835 (2005)

    Article  PubMed  CAS  Google Scholar 

  23. Naglik, J.R., Rodgers, C.A., Shirlaw, P.J., et al.: Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J. Infect. Dis. 188, 469–479 (2003)

    Article  PubMed  CAS  Google Scholar 

  24. Schaller, M., Bein, M., Korting, H.C., et al.: The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect. Immun. 71, 3227–3234 (2003)

    Article  PubMed  CAS  Google Scholar 

  25. Soll, D.R.: High-frequency switching in Candida albicans and its relations to vaginal candidiasis. Am. J. Obstet. Gynecol. 158, 997–1001 (1988)

    PubMed  CAS  Google Scholar 

  26. Reed, B.D., Zazove, P., Pierson, C.L., Gorenflo, D.W., Horrocks, J.: Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis. J. Womens Health (Larchmt) 12, 979–989 (2003)

    Article  Google Scholar 

  27. Chaim, W., Foxman, B., Sobel, J.D.: Association of recurrent vaginal candidiasis and secretory ABO and Lewis phenotype. J. Infect. Dis. 176, 828–830 (1997)

    Article  PubMed  CAS  Google Scholar 

  28. Babula, O., Lazdane, G., Kroica, J., Linhares, I.M., Ledger, W.J., Witkin, S.S.: Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin. Infect. Dis. 40, 1258–1262 (2005)

    Article  PubMed  CAS  Google Scholar 

  29. Cotch, M.F.: Vaginal carriage of Candida spp in pregnancy. In: Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 1991, p. 307.

    Google Scholar 

  30. Young, G.L., Jewell, D.: Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database Syst. Rev. 2006, 2.

    Google Scholar 

  31. Tarry, W., Fisher, M., Shen, S., Mawhinney, M.: Candida albicans: the estrogen target for vaginal colonization. J. Surg. Res. 129, 278–282 (2005)

    Article  PubMed  CAS  Google Scholar 

  32. Foxman, B.: The epidemiology of vulvovaginal candidiasis: risk factors. Am. J. Public Health 80, 329–331 (1990)

    Article  PubMed  CAS  Google Scholar 

  33. Barbone, F., Austin, H., Louv, W.C., Alexander, W.J.: A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am. J. Obstet. Gynecol. 163, 510–514 (1990)

    PubMed  CAS  Google Scholar 

  34. Demirezen, S., Dirlik, O.O., Beksac, M.S.: The association of Candida infection with intrauterine contraceptive device. Cent. Eur. J. Public Health 13, 32–34 (2005)

    PubMed  CAS  Google Scholar 

  35. de Leon, E.M., Jacober, S.J., Sobel, J.D., Foxman, B.: Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect. Dis. 2, 1–4 (2002)

    Article  PubMed  Google Scholar 

  36. Donders, G.G., Prenen, H., Verbeke, G., Reybrouck, R.: Impaired tolerance for glucose in women with recurrent vaginal candidiasis. Am. J. Obstet. Gynecol. 187, 989–993 (2002)

    Article  PubMed  Google Scholar 

  37. Ehrström, S., Yu, A., Rylander, E.: Glucose in vaginal secretions before and after oral glucose tolerance testing in women with and without recurrent vulvovaginal candidiasis. Obstet. Gynecol. 108(6), 1432–1437 (2006)

    Article  PubMed  Google Scholar 

  38. Spinillo, A., Capuzzo, E., Acciano, S., De Santolo, A., Zara, F.: Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis. Am. J. Obstet. Gynecol. 180, 14–17 (1999)

    Article  PubMed  CAS  Google Scholar 

  39. Pirotta, M.V., Gunn, J.M., Chondros, P.: “Not thrush again!” Women’s experience of post-antibiotic vulvovaginitis. Med. J. Aust. 179, 43–46 (2003)

    PubMed  Google Scholar 

  40. Oriel, J.D., Waterworth, P.M.: Effects of minocycline and tetracycline on the vaginal yeast flora. J. Clin. Pathol. 28, 403–406 (1975)

    Article  PubMed  CAS  Google Scholar 

  41. Pirotta, M.V., Garland, S.M.: Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics. J. Clin. Microbiol. 44, 3213–3217 (2006)

    Article  PubMed  Google Scholar 

  42. Bradshaw, C.S., Morton, A.N., Garland, S.M., Morris, M.B., Moss, L.M., Fairley, C.K.: Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet. Gynecol. 106, 105–114 (2005)

    Article  PubMed  Google Scholar 

  43. Neves, N.A., Carvalho, L.P., De Oliveira, M.A., et al.: Association between atopy and recurrent vaginal candidiasis. Clin. Exp. Immunol. 142, 167–171 (2005)

    Article  PubMed  CAS  Google Scholar 

  44. Carvalho, L.P., Bacellar, O., Neves, N., de Jesus, A.R., Carvalho, E.M.: Downregulation of IFN-gamma production in patients with recurrent vaginal candidiasis. J. Allergy Clin. Immunol. 109, 102–105 (2002)

    Article  PubMed  CAS  Google Scholar 

  45. Schaaf, V.M., Perez-Stable, E.J., Borchardt, K.: The limited value of symptoms and signs in the diagnosis of vaginal infections. Arch. Intern. Med. 150, 1929–1933 (1990)

    Article  PubMed  CAS  Google Scholar 

  46. Bergman, J.J., Berg, A.O., Schneeweiss, R., Heidrich, F.E.: Clinical comparison of microscopic and culture techniques in the diagnosis of Candida vaginitis. J. Fam. Pract. 18, 549–552 (1984)

    PubMed  CAS  Google Scholar 

  47. Sobel, J.D., Kapernick, P.S., Zervos, M., et al.: Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am. J. Obstet. Gynecol. 185, 363–369 (2001)

    Article  PubMed  CAS  Google Scholar 

  48. Reef, S.E., Levine, W.C., McNeil, M.M., et al.: Treatment options for vulvovaginal candidiasis, 1993. Clin. Infect. Dis. 20(Suppl 1), S80–S90 (1995)

    Article  PubMed  Google Scholar 

  49. Watson, M.C., Grimshaw, J.M., Bond, C.M., Mollison, J., Ludbrook, A.: Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review. BJOG 109, 85–95 (2002)

    Article  PubMed  CAS  Google Scholar 

  50. Davidson, F., Mould, R.F.: Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment. Br. J. Vener. Dis. 54, 176–183 (1978)

    PubMed  CAS  Google Scholar 

  51. Fong, I.W.: The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole. Genitourin. Med. 68, 174–176 (1992)

    PubMed  CAS  Google Scholar 

  52. Dennerstein, G.J.: Depo-Provera in the treatment of recurrent vulvovaginal candidiasis. J. Reprod. Med. 31, 801–803 (1986)

    PubMed  CAS  Google Scholar 

  53. Rigg, D., Miller, M.M., Metzger, W.J.: Recurrent allergic vulvovaginitis: treatment with Candida albicans allergen immunotherapy. Am. J. Obstet. Gynecol. 162, 332–336 (1990)

    PubMed  CAS  Google Scholar 

  54. Rosedale, N., Browne, K.: Hyposensitisation in the management of recurring vaginal candidiasis. Ann. Allergy 43, 250–253 (1979)

    PubMed  CAS  Google Scholar 

  55. Mathema, B., Cross, E., Dun, E., et al.: Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole antifungals. Clin. Infect. Dis. 33, E23–E27 (2001)

    Article  PubMed  CAS  Google Scholar 

  56. Sobel, J.D., Vazquez, J.A.: Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus. Clin. Infect. Dis. 22, 726–727 (1996)

    Article  PubMed  CAS  Google Scholar 

  57. Richter, S.S., Galask, R.P., Messer, S.A., Hollis, R.J., Diekema, D.J., Pfaller, M.A.: Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J. Clin. Microbiol. 43, 2155–2162 (2005)

    Article  PubMed  CAS  Google Scholar 

  58. Sobel, J.D., Zervos, M., Reed, B.D., et al.: Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob. Agents Chemother. 47, 34–38 (2003)

    Article  PubMed  CAS  Google Scholar 

  59. Moosa, M.Y., Sobel, J.D., Elhalis, H., Du, W., Akins, R.A.: Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium. Antimicrob. Agents Chemother. 48, 161–167 (2004)

    Article  PubMed  CAS  Google Scholar 

  60. Sobel, J.D., Chaim, W., Nagappan, V., Leaman, D.: Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am. J. Obstet. Gynecol. 189, 1297–1300 (2003)

    Article  PubMed  CAS  Google Scholar 

  61. Phillips, A.J.: Treatment of non-albicans Candida vaginitis with amphotericin B vaginal suppositories. Am. J. Obstet. Gynecol. 192, 2009–2012 (2005)

    Article  PubMed  CAS  Google Scholar 

  62. Rhoads, J.L., Wright, D.C., Redfield, R.R., Burke, D.S.: Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 257, 3105–3107 (1987)

    Article  PubMed  CAS  Google Scholar 

  63. Duerr, A., Heilig, C.M., Meikle, S.F., et al.: Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: Risk factors and severity. Obstet. Gynecol. 101, 548–556 (2003)

    Article  PubMed  Google Scholar 

  64. Sobel, J.D., Ohmit, S.E., Schuman, P., et al.: The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J. Infect. Dis. 183, 286–293 (2001)

    Article  PubMed  CAS  Google Scholar 

  65. Schuman, P., Capps, L., Peng, G., et al.: Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. Ann. Intern. Med. 126, 689–696 (1997)

    PubMed  CAS  Google Scholar 

  66. Vazquez, J.A., Peng, G., Sobel, J.D., et al.: Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis. Clin. Infect. Dis. 33, 1069–1075 (2001)

    Article  PubMed  CAS  Google Scholar 

  67. Mostad, S.B., Overbaugh, J., DeVange, D.M., et al.: Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 350, 922–927 (1997)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Wayne State University School of Medicine, Detroit, MI, USA

    Jack D. Sobel

Authors
  1. Jack D. Sobel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jack D. Sobel .

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für, Dermatologie und Venerologie, Universitätsklinikum Rostock, Strempelstraße 13-85, Rostock, 18057, Mecklenburg-Vorpomm., Germany

    Gerd E. Gross

  2. University of Texas Health Science Cente, 451 North Texas Avenue, Houston, 77598, Texas, USA

    Stephen K. Tyring

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Sobel, J.D. (2011). Genital Candidiasis. In: Gross, G., Tyring, S. (eds) Sexually Transmitted Infections and Sexually Transmitted Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-14663-3_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-14663-3_46

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-14662-6

  • Online ISBN: 978-3-642-14663-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation